Vallon Pharmaceuticals, Inc. (27)

Browse by Contract Category

Contracts

Description of the securities of Vallon Pharmaceuticals, Inc. registered under Section 12 of the Exchange Act (Filed With SEC on March 29, 2021)
Form of Representatives Warrant (Filed With SEC on February 16, 2021)
Voting Agreement, dated as of December 30, 2020, by and among Vallon Pharmaceuticals, Inc (Filed With SEC on January 14, 2021)
Form of Nonqualified Stock Option Agreement under Vallon Pharmaceuticals, Inc. 2018 Equity Incentive Plan (Filed With SEC on January 14, 2021)
License Agreement, effective as of January 6, 2020, by and between Vallon Pharmaceuticals, Inc. and MEDICE Arzneimittel Putter GmbH & Co. KG (Filed With SEC on November 16, 2020)
Underwriting Agreement, dated February 9, 2021, between the Company and ThinkEquity, a division of Fordham Financial Management, Inc (Filed With SEC on February 16, 2021)
Form of Underwriter Warrant (Filed With SEC on January 28, 2021)
Specimen certificate evidencing shares of common stock (Filed With SEC on January 28, 2021)
Form of Underwriting Agreement (Filed With SEC on January 28, 2021)
Form of Stock Purchase Agreement, dated June 7, 2018, among Vallon Pharmaceuticals, Inc. and the investors listed therein (Filed With SEC on January 14, 2021)
Form of Convertible Promissory Note (Filed With SEC on January 14, 2021)
Form of Convertible Promissory Note Purchase Agreement, dated as of January 11, 2021, by and among Vallon Pharmaceuticals and the investors named therein (Filed With SEC on January 14, 2021)
Form of Lock Up Agreement (Filed With SEC on January 14, 2021)
Investors Rights Agreement, dated as of July 25, 2019, by and between Vallon Pharmaceuticals, Inc. and Salmon Pharma GmbH (Filed With SEC on January 14, 2021)
Form of Stock Purchase Agreement, dated July 25, 2019, between Vallon Pharmaceuticals, Inc (Filed With SEC on January 14, 2021)
Form of Subscription Agreement (Filed With SEC on January 14, 2021)
Patent and Patent Application Assignment Agreement between Arcturus Therapeutics, Ltd. and Vallon Pharmaceuticals, Inc., dated June 22, 2018 (Filed With SEC on January 14, 2021)
Form of Directors and Officers Indemnity Agreement (Filed With SEC on January 14, 2021)
Employment Agreement between Vallon Pharmaceuticals, Inc. and David Baker, dated January 15, 2019 (Filed With SEC on January 14, 2021)
Employment Agreement between Vallon Pharmaceuticals, Inc. and Penny S. Toren, dated April 2, 2018 (Filed With SEC on January 14, 2021)
Consulting Agreement with Whitaker Biopharmaceutical Consulting LLC, dated April 2, 2018 (Filed With SEC on January 14, 2021)
Amended and Restated Asset Purchase Agreement, dated as of June 22, 2017, by and among Arcturus Therapeutics, Ltd. (and its subsidiary, Arcturus Therapeutics, Inc.), Amiservice... (Filed With SEC on January 14, 2021)
Form of Convertible Promissory Note (Filed With SEC on October 23, 2020)
Form of Incentive Stock Option Agreement under Vallon Pharmaceuticals, Inc. 2018 Equity Incentive Plan (Filed With SEC on October 23, 2020)
Form of Stock Option Agreement under Vallon Pharmaceuticals, Inc. 2018 Equity Incentive Plan (Filed With SEC on October 23, 2020)
Vallon Pharmaceuticals, Inc. 2018 Equity Incentive Plan (Filed With SEC on October 23, 2020)
Convertible Promissory Note Purchase Agreement, dated as of April 11, 2019 (Filed With SEC on October 23, 2020)